Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer

Name: Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer
License: Public Domain

Emory University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

advanced hepatocellular carcinoma, metastatic hepatocellular carcinoma, stage iii hepatocellular carcinoma ajcc v8, stage iv hepatocellular carcinoma ajcc v8

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 366587
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.